News
New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...
On behalf of our sponsors at Arcutis Biotherapeutics, we're learning more about Plaque Psoriasis, the chronic, inflammatory skin disease that affects many people and a new topical treatment that may ...
From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.
One of the more serious side effects from immune checkpoint inhibitor (ICI) therapies for cancer is new-onset or worsened ...
A new international study led by researchers at McMaster University has identified the most effective and safest treatments ...
A large cohort study of patients with psoriasis using wearable devices finds more exercise is associated with a lower risk ...
A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...
2d
Everyday Health on MSNHow to Spot and Treat Inverse PsoriasisInverse psoriasis, which causes painful lesions on sensitive skin folds, can be hard to treat. Find out more about this type of psoriasis.
Guselkumab and risankizumab for psoriasis have the highest rates of drug survival among biologics measured and a comparable safety profile.
John McEnroe is on the call of the men's championship match at Wimbledon on Sunday. The iconic American tennis player, who ...
Boehringer Ingelheim and LEO Pharma have signed an exclusive global license and transfer agreement to commercialize and ...
3d
Health on MSNWhat To Know About Guttate Psoriasis in Adults and ChildrenMedically reviewed by Katlein Franca, MD Guttate psoriasis causes small, round bumps. It's typically triggered by a Streptococcus (strep) bacteria infection. Guttate psoriasis most commonly affects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results